Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Study in Hepatocellular Carcinoma Patients Underwent TACE

NCT05291338 is registered in ClinicalTrials.gov with Rehab Werida as lead sponsor.

NCT NCT05291338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Study in Hepatocellular Carcinoma Patients Underwent TACE
Lead sponsor
Rehab Werida
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
April 1, 2023
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma